Untreated attention-deficit/hyperactivity disorder (ADHD) can lead to substantial adverse
social, economic, and emotional outcomes for patients. The effectiveness of current …

Background Stimulants are the first–line medication in the psychopharmacological treatment
of attention–deficit hyperactivity disorder (ADHD). However, 10 to 30% of all children and …

OBJECTIVE:: In the intent-to-treat analysis of the Multimodal Treatment Study of Children
With ADHD (MTA), the effects of medication management (MedMgt), behavior therapy (Beh) …

Computerized working memory and executive function training programs designed to target
specific impairments in executive functioning are becoming increasingly available, yet how …

Medication administration errors that take place in the home are common, especially when
liquid preparations are used and complex medication schedules with multiple medications …

Background: The efficacy of methylphenidate for adults with attention-deficit hyperactivity
disorder (ADHD) shows wide between-study variability, which yields heterogeneous results …

Executive functions (EFs) refer to a family of higher order, interrelated cognitive processes
that enable a wide range of activities such as goal directed behavior, reasoning, planning …

Attention deficit hyperactivity disorder (ADHD) is a neurocognitive behavioral developmental
disorder most commonly seen in childhood and adolescence, which often extends to the …

Background: The osmotic-controlled release oral delivery system, OROS, is an advanced
drug delivery technology that uses osmotic pressure as the driving force to deliver …

The onset of attention-deficit-hyperactivity-disorder (ADHD) in childhood is characterized by
developmentally inappropriate levels of hyperactivity, impulsivity and inattention. A chronic …